Outset Medical, Inc. (OM) has a negative trailing P/E of -0.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -111.91%.
Criteria proven by this page:
Overall SharesGrow Score: 49/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2018 | -36.7 | 0.00 | -6.34 | 909.52 | - |
| 2019 | -26.7 | 11.02 | -4.90 | 121.06 | - |
| 2020 | -20.0 | -0.26 | 7.39 | 48.63 | - |
| 2021 | -15.9 | -0.01 | 5.62 | 20.48 | - |
| 2022 | -7.6 | -0.45 | 5.06 | 10.78 | - |
| 2023 | -1.6 | -0.52 | 2.18 | 2.06 | - |
| 2024 | -0.5 | 0.02 | 2.15 | 0.51 | - |
| 2025 | -0.7 | 0.01 | 0.44 | 0.47 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2018 | $-1.65 | $2.01M | $-49.78M | -2480.3% |
| 2019 | $-1.61 | $15.08M | $-68.3M | -453% |
| 2020 | $-2.83 | $49.94M | $-120.7M | -241.7% |
| 2021 | $-2.89 | $102.6M | $-131.94M | -128.6% |
| 2022 | $-3.38 | $115.38M | $-162.96M | -141.2% |
| 2023 | $-3.48 | $130.38M | $-172.8M | -132.5% |
| 2024 | $-2.46 | $113.69M | $-127.98M | -112.6% |
| 2025 | $-5.37 | $119.48M | $-81.65M | -68.3% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-2.82 | $-2.83 – $-2.81 | $126.63M | $125.91M – $127.5M | 2 |
| 2027 | $-2.35 | $-2.66 – $-2.03 | $140.79M | $140M – $141.76M | 2 |
| 2028 | $-1.79 | $-1.81 – $-1.78 | $160.4M | $159.49M – $161.5M | 1 |
| 2029 | $-1.13 | $-1.14 – $-1.12 | $179.1M | $178.09M – $180.33M | 1 |
| 2030 | $-0.26 | $-0.26 – $-0.26 | $199.7M | $198.57M – $201.07M | 1 |
